BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 17, 2010
View Archived Issues
Clinical data on Gardasil reported at EUROGIN meeting
Read More
Takeda claims new GPR52 receptor agonists for schizophrenia
Read More
Merck & Co. patents new CGRP receptor antagonists
Read More
Genentech discovers novel IAP inhibitors for treatment of cancer
Read More
Advenchen claims new tyrosine kinase inhibitors for cancer therapy
Read More
Allergan discloses novel prostanoid EP2 receptor agonists
Read More
Merck & Co. reports clinical data on mometasone furoate/formoterol fumarate in asthma
Read More
Patient enrollment ongoing in phase II trial of pioglitazone in intracerebral hemorrhage
Read More
Ipsen initiates dosing in two phase II studies of BIM-23A760 in cancer
Read More
Viron reports preclinical results on VT-346 in arthritis
Read More
LLS and Forma to develop new therapies for diffuse large B-cell lymphoma
Read More
Dynavax expects earlier BLA submission for Heplisav
Read More
Medicago and MOU partner to commercially develop influenza vaccines in Japan
Read More
DARPA awards funds to Fraunhofer USA CMB for development H1N1 vaccine
Read More
Lilly to acquire worldwide license to Acrux's testosterone solution Axiron
Read More
Nuvo begins enrollment in phase II trial of WF-10 in allergic rhinitis
Read More
DEF-201 active against Western equine encephalitis virus, a potential biothreat
Read More
Hantavirus DNA vaccines safe and well tolerated in phase I study
Read More
bioMerieux launches screening tool for vancomycin-resistant enterocci in U.S.
Read More
Tekmira and Pfizer collaborate on stable nucleic acid-lipid particle technology
Read More
Genentech submits Actemra sBLA to FDA for additional RA indication
Read More
Third dose group treated in PCI Biotech's phase I/II trial of Amphinex in cancer
Read More
Iverson Genetic Diagnostics to evaluate gene-based testing before warfarin anticoagulation therapy
Read More
FDA to review primary data from ACCORD lipid trial
Read More
Lundbeck initiates phase II trial of desmoteplase for ischemic stroke in Japan
Read More